The efficacy and safety of docetaxel-based chemotherapy combined with dexamethasone 1 mg daily oral administration: JMTO Pca 10-01 phase II trial

A Randomised Phase 2 Trial of Dexamethasone Versus Prednisolone in Castration-resistant Prostate Cancer

(2015) Ramachandran Venkitaraman et al.   EUROPEAN UROLOGY

Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy

(2012) Charles J. Ryan et al.   NEW ENGLAND JOURNAL OF MEDICINE

A multi-centre randomised phase III trial of Dexamethasone vs Dexamethasone and diethylstilbestrol in castration-resistant prostate cancer: immediate vs deferred Diethylstilbestrol

(2011) J Shamash et al.   BRITISH JOURNAL OF CANCER

Abiraterone and Increased Survival in Metastatic Prostate Cancer

(2011) Johann S. de Bono et al.   NEW ENGLAND JOURNAL OF MEDICINE

PSA surge/flare-up in patients with castration-refractory prostate cancer during the initial phase of chemotherapy

(2009) T. Nelius et al.   PROSTATE

Prostate-specific antigen flare phenomenon with docetaxel-based chemotherapy in patients with androgen-independent prostate cancer

(2008) Avishay Sella et al.   BJU INTERNATIONAL

Docetaxel Plus Prednisolone for the Treatment of Metastatic Hormone-refractory Prostate Cancer: A Multicenter Phase II Trial in Japan

(2008) S. Naito et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY